Trending
Revolutionary Shows Promise 4
Revolutionary Shows Promise 3
Revolutionary Shows Promise 1
Revolutionary aids Treatment Shows Promise
Revolutionary Cancer Treatment Shows Promise
FDA Expands Approval of Vonvendi for von Willebrand Disease, Including Pediatric Use
Child Depression Fluctuations may trigger Parent Depression not vice versa: JAMA
Indoor Air Quality and Diet Found to Regulate Inflammation in Childhood: Study Finds
How Smoking Fuels Pancreatic Cancer Growth and Worsens Outcomes: Study Finds Out
Follow Us:
November 07, 2025

Get In Touch

20% Of Patients Develop Heart Complications After Major Non-Cardiac Surgery : Study Surgery

20% Of Patients Develop Heart Complications After Major Non-Cardiac Surgery : Study

  • 27 July 2025
  • 3 months ago

One-Month Of DAPT Good Enough After DES Placement, Finds Study Cardiology and CTVS

One-Month Of DAPT Good Enough After DES Placement, Finds Study

  • 27 July 2025
  • 3 months ago

Can Timing Of Nontarget-Vessel PCI Impact Patients With ACS & Multivessel Disease ? Cardiology and CTVS

Can Timing Of Nontarget-Vessel PCI Impact Patients With ACS & Multivessel Disease ?

  • 27 July 2025
  • 3 months ago

Cinnamon Beneficial For High BP Patients, Finds Study Diet

Cinnamon Beneficial For High BP Patients, Finds Study

  • 27 July 2025
  • 3 months ago

Vena Cava Filters Safe And Effective For Preventing Pulmonary Embolism In DVT Patients: PRESERVE Trial Surgery

Vena Cava Filters Safe And Effective For Preventing Pulmonary Embolism In DVT Patients: PRESERVE Trial

  • 27 July 2025
  • 3 months ago

Patients With Type A Aortic Dissection Have 3-Fold Higher Risk Of Stroke In Long-Term: JAHA Cardiology and CTVS

Patients With Type A Aortic Dissection Have 3-Fold Higher Risk Of Stroke In Long-Term: JAHA

  • 27 July 2025
  • 3 months ago

Concomitant Renal Dysfunction Mitigates Clinical Benefit Of Milrinone In Cardiogenic Shock Patients: JACC Study Cardiology and CTVS

Concomitant Renal Dysfunction Mitigates Clinical Benefit Of Milrinone In Cardiogenic Shock Patients: JACC Study

  • 27 July 2025
  • 3 months ago

Rivaroxaban To Prevent Clinical Outcomes In Covid 19 Patients: MICHELLE TRIAL Cardiology and CTVS

Rivaroxaban To Prevent Clinical Outcomes In Covid 19 Patients: MICHELLE TRIAL

  • 27 July 2025
  • 3 months ago

Molidustat, A Promising Drug To Minimize HF Risk Following Heart Attack In Diabetics Laboratory Medicine

Molidustat, A Promising Drug To Minimize HF Risk Following Heart Attack In Diabetics

  • 27 July 2025
  • 3 months ago

Ankle Fracture Patients At Higher Risk Of Venous Thromboembolism: Study Medicine

Ankle Fracture Patients At Higher Risk Of Venous Thromboembolism: Study

  • 27 July 2025
  • 3 months ago

Recent News

Scientists uncover hidden blood biomarkers reveali...

  • 07 November, 2025

Private medical college moves Bombay HC seeking in...

  • 07 November, 2025

Doctors move Health Ministry, MCC over procedural...

  • 07 November, 2025

PG Medical Admissions 2025 registration begin in U...

  • 07 November, 2025

Daily Newsletter

Get all the top stories from Blogs to keep track.